Trevena Inc
TRVNDelisted Apr 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001429560
Trevena Inc was delisted on Apr 8, 2025; its insiders filed their last Form 4 on Oct 10, 2024; no institution reported holding it in 13F filings for Q1 2025; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in Trevena Inc as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 1
- −14 vs. Q3 2024
- Shares held
- 4
- −37.6K (−100.0%) vs. Q3 2024
- Total value
- $6
- −$82.7K (−100.0%) vs. Q3 2024
- New holders
- 0
- 0 more added
- Sold out
- 14
- 0 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $6 |
| Q3 2024 | 16 | $82.7K |
| Q2 2024 | 29 | $184.1K |
| Q1 2024 | 26 | $1.03M |
| Q4 2023 | 27 | $1.05M |
| Q3 2023 | 29 | $419.7K |
| Q2 2023 | 29 | $596.8K |
| Q1 2023 | 35 | $665.9K |
| Q4 2022 | 35 | $2.00M |
| Q3 2022 | 60 | $3.04M |
| Q2 2022 | 71 | $8.87M |
| Q1 2022 | 81 | $18.2M |
| Q4 2021 | 84 | $20.5M |
| Q3 2021 | 83 | $45.5M |
| Q2 2021 | 86 | $60.1M |
| Q1 2021 | 84 | $49.9M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Trevena Inc; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Activest Wealth Management | 4 | $6 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 0 | $0 | 0.00% | −13,346−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −5,309−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,144−100.0% | Sold out |
| Summit X, LLC | 0 | $0 | 0.00% | −16,408−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −872−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −407−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| DecisionPoint Financial, LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Bokf, NA | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Planning Capital Management Corp | – | – | – | – | Not filed |